发明名称 |
Composition for therapeutic use, including an organic lipid phase and a rare-earth radioisotope complex |
摘要 |
The invention relates to a therapeutic composition including a complex having the following formula (1), including a rare-earth radioisotope in ionic form, said complex being solubilized in an organic lipophilic phase: [M(L)3] in which: M denotes the rare-earth radioisotope in ionic form, and L denotes a tropolone ligand or a ligand derived from tropolone. |
申请公布号 |
US9579409(B2) |
申请公布日期 |
2017.02.28 |
申请号 |
US201314415282 |
申请日期 |
2013.07.17 |
申请人 |
CENTRE EUGENE MARQUIS;ECOLE NATIONALE SUPERIEURE DE CHIME;UNIVERSITE DE RENNES I |
发明人 |
Lepareur Nicolas;Garin Etienne;Noiret Nicolas;Ardisson Valerie |
分类号 |
A61P35/00;A61K103/32;A61K103/30;A61K51/04;A61K51/12 |
主分类号 |
A61P35/00 |
代理机构 |
Thomas | Horstemeyer, LLP |
代理人 |
Thomas | Horstemeyer, LLP |
主权项 |
1. A therapeutical composition, comprising a complex having the following formula (1) comprising a rare-earth radioisotope, said complex being solubilized in a lipophilic organic phase:
[M(L)3] (1)wherein:
M designates the rare-earth radioisotope, wherein the rare-earth radioisotope is 90Y or 47Sc, and L designates a tropolone ligand or a tropolone-derived ligand chosen from amongst halogenotropolone, α-methyltropolone, β-methyltropolone, γ-methyltropolone, α-isopropyltropolone, β-isopropyltropolone, γ-isopropyltropolone, nootkatin, stipitatic acid, puberulic acid, puberulonic acid, purpurogallin, or colchicine. |
地址 |
Rennes FR |